American Lung Association to Release 2025 New Jersey ‘State of Tobacco Control’ Report on January 29
Thursday, January 23, 2025
New report examines efforts to reduce and prevent tobacco use by state and at federal level
TRENTON – (January 22, 2025) – On Wednesday, January 29, the American Lung Association in New Jersey will release the 23rd annual “State of Tobacco Control” report. Access to the embargoed report and embargoed interviews are available upon request.
Access to the embargoed report and embargoed interviews are available. To request, please email [email protected] with a written acknowledgement of embargo date.
WHAT: The American Lung Association’s 23rd annual “
WHEN: The embargo on the 2025 “State of Tobacco Control” report lifts on Wednesday, January 29 at 12:01 a.m. Eastern Time.
WHERE: New findings from the “State of Tobacco Control” report for New Jersey will be live on Lung.org/sotc following the launch. Embargoed report findings and embargoed interviews are available upon request.
WHO: The following spokespeople are available for media interviews on report findings and health impacts of tobacco use:
- Michael Seilback, AVP, Nationwide Advocacy, American Lung Association
- Andrew Berman, MD, NJ Local Leadership Board, American Lung Association; Professor, Rutgers New Jersey Medical School Division Director, Pulmonary and Critical Care Medicine, Allergy and Rheumatology, Rutgers New Jersey Medical School
- Thomas Carr, report lead author, Director, Nationwide Policy, American Lung Association
- Medical experts, including pulmonologists and lung cancer experts
WHY: Tobacco use remains the leading cause of preventable death and disease here in New Jersey and across America, killing 490,000 people nationally each year. The report not only grades states and the federal government but also identifies key actions for lawmakers to take to eliminate the death and disease caused by tobacco use.
HOW: To request embargoed report findings or an embargoed interview, contact Val Gleason at [email protected] or 717-971-1123.